PROSTATE DUCTAL ADENOCARCINOMA

Clinical trials for PROSTATE DUCTAL ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new PROSTATE DUCTAL ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for PROSTATE DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New combo therapy trial aims to stop prostate Cancer's spread

Disease control Recruiting now

This study is for men whose prostate cancer has spread to a limited number of other body sites but still responds to hormone therapy. It compares standard radiation treatment alone to radiation combined with a daily pill (relugolix) that lowers testosterone. The goal is to see if…

Matched conditions: PROSTATE DUCTAL ADENOCARCINOMA

Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Disease control

Last updated Mar 19, 2026 14:55 UTC

PROSTATE DUCTAL ADENOCARCINOMA

Get alerted when new PROSTATE DUCTAL ADENOCARCINOMA trials appear

New combo therapy trial aims to stop prostate Cancer's spread